International Case-Control Study of DNA Methylation Biomarkers for the Minimally Invasive Diagnosis of Esophageal Squamous Cell Carcinoma
Authors:
- Yulan ChengYCYulan Cheng
- Adithi BanavarABAdithi Banavar
- Ke MaKMKe Ma
- Paul Stephen ObwoyaPOPaul Stephen Obwoya
- Kija LuhutiKLKija Luhuti
- Caleb TuhumwireCTCaleb Tuhumwire
- Shayan GheshlaghiSGShayan Gheshlaghi
- Kelly FanKFKelly Fan
- Yifan YangYYYifan Yang
- Kuangwen HsiehKHKuangwen Hsieh
- Alexander C. HasnainAHAlexander C. Hasnain
- Yousra AhmedYAYousra Ahmed
Open Access
- 11 September 2026
- journal article
- Published by Wolters Kluwer Health in Clinical and Translational Gastroenterology
Abstract
INTRODUCTION: Esophageal squamous cell carcinoma (ESCC), the most common type of esophageal cancer worldwide, is usually diagnosed by esophagogastroduodenoscopy, an expensive procedure having limited availability in low- and middle-income countries. We therefore developed a diagnostic strategy that applies ESCC-specific DNA methylation biomarkers to nonendoscopically-obtained esophageal mucosal samples. METHODS: We used a novel approach based on a search of 5 publicly available GEO and TCGA datasets, which contained 196 organ-specific normal controls. We selected 6 new methylation markers, combining these with 5 markers identified in a previous study. We then performed a case-control analysis of 174 esophageal cytologic samples collected using a swallowable sponge-capsule device, one sample each from 93 patients with ESCC and 81 noncancer control patients. Based on these molecular data, a classification algorithm was built in a training set of 122 patients using the least absolute shrinkage and selection operator (LASSO) method, which was then tested in a separate cohort of 52 patients. Coefficients of the LASSO regression model were used to select markers that contributed most strongly to the classification. RESULTS: All 11 markers tested exhibited significantly higher methylation levels in all 93 ESCC sponge samples than in 81 normal control sponges, with P -values below 0.001. Furthermore, individual areas under the receiver operating characteristic curve (AUCs) for the 11 markers, C1ORF70, PPFIA3, SKOR1, ZNF132, TAC1, JPH4, ZNF542, KLF16, CG20655070, SLC35, and PAX9, were 0.91, 0.90, 0.89, 0.89, 0.89, 0.89, 0.87, 0.87, 0.83, 0.82, 0.81, and 0.65, respectively. Based on LASSO regression applied to all 11 markers, 4 (C1ORF70, CG20655070, SKOR1, and PPFIA3) were retained in our final model. A composite score based on this final model achieved an area under the receiver operating characteristic curve of 0.93 in the 122-patient training cohort and 0.92 in the 52-patient test set. DISCUSSION: When used in combination with a minimally invasive sponge-capsule device, ESCC methylation biomarkers may improve the diagnosis of ESCC. This strategy harbors potential to mitigate the deadly worldwide public health impact of ESCC.Keywords
Funding Information
- National Cancer Institute (CA279866)
- National Cancer Institute (CA211457)
This publication has 46 references indexed in Scilit:
- DNA methylation patterns in the frontal lobe white matter of multiple system atrophy, Parkinson’s disease, and progressive supranuclear palsy: a cross-comparative investigationActa Neuropathologica, 2024
- A syndromic neurodevelopmental disorder caused by rare variants in PPFIA3The American Journal of Human Genetics, 2024
- Algorithm Training and Testing for a Nonendoscopic Barrett’s Esophagus Detection Test in Prospective Multicenter CohortsClinical Gastroenterology and Hepatology, 2024
- Epigenetic clock and DNA methylation analysis of porcine models of aging and obesityGeroScience, 2021
- Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation setAnnals of Oncology, 2021
- Minimally invasive esophageal sponge cytology sampling is feasible in a Tanzanian community settingInternational Journal of Cancer, 2020
- DNA Methylation Biomarkers for the Diagnosis of Barrett's OesophagusAmerican Journal of Gastroenterology, 2018
- Highly Discriminant Methylated DNA Markers for the Non-endoscopic Detection of Barrett's EsophagusAmerican Journal of Gastroenterology, 2018
- Genomic and Epigenomic Profiling of High-Risk Intestinal Metaplasia Reveals Molecular Determinants of Progression to Gastric CancerCancer Cell, 2018
- Establishment of a DNA methylation marker to evaluate cancer cell fraction in gastric cancerGastric Cancer, 2015